How Do We Facilitate the Implementation of Needed Novel HTA Methodologies in National and EU HTA Practice?

The EU has invested in developing new health technology assessment (HTA) methodologies through IMI and Horizon EU projects for over ten years. Additionally, HTA bodies have started to work differently, from systematic reviews and ample indications to submission-based work for small and targeted populations. Moreover, the EU HTA Regulation, which will require the first joint assessments to take place in 2025, will affect how HTA bodies work nationally. Finally, there is a growing feeling that data from clinical practice (often referred to as real-world data/evidence) may have a role in HTA next to randomized controlled trials (RCTs).

However, developments in HTA methodologies may usually not match the needs of HTA bodies. How do we better align HTA needs to academic HTA methods development? In the panel, we will introduce a new EU Horizon Europe-funded project, SUSTAIN-HTA, that aims to bring academic developments in HTA methodology closer to the HTA needs. Two representatives from NICE and Central and Eastern Europe (Ukraine) will indicate the need for such a project. Additionally, a researcher from a well established research institute from Hungary will indicate the importance of SUSTAIN-HTA of bridging academic HTA development to HTA methods implementation and in particular how further development of transferability may ensure adequate and tailored HTA methods for the different contexts in Europe.